CBPO - China Biologic Products, Inc. - Insider Stock Trading - OpenInsider

18 results - M - W - D

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	1	3	18	-1	-2	-10	-13	-3	48	3
P	%wins				50	44	28	28	28	72	42

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
5/15/13 17:10	5/14/13	CBPO	Health	BioPrd	Biological Products, (No Diag	Wp X Biologics LLC	NY	DT		P	62,258	20.00	1	3,113	40	10,989	D	79	178	131	42	-4	-2	-3	-2	0	2	-13	-9	9	56
9/17/12 16:40	9/13/12	CBPO	Health	BioPrd	Biological Products, (No Diag	Gao David	F4	DO	CEO	P	45	8.93	0	5	71	12	D	0	23	4	3	-7	-2	7	8	-1	-3	-1	60	190	156
6/5/12 14:07	6/1/12	CBPO	Health	BioPrd	Biological Products, (No Diag	Warburg Pincus Private Equity X, L.P.	NY	DT		P	20,105	12.50	0	1,608	26	7,876	D	-33	-17	-5	-6	-9	1	7	1	2	19	12	12	71	187
5/15/12 07:59	5/14/12	CBPO	Health	BioPrd	Biological Products, (No Diag	Gao David	F4	DO	CEO	P	26	9.50	0	3	63	7	I	-36	-39	17	-14	-9	-10	-2	-7	-3	-4	18	14	31	209
5/14/12 13:11	5/11/12	CBPO	Health	BioPrd	Biological Products, (No Diag	Gao David	F4	DO	CEO	P.d	41	9.50	0	4	New	4	I	-30	-32	34	-2	3	1	6	9	-12	-15	5	8	15	171
12/19/11 16:31	12/16/11	CBPO	Health	BioPrd	Biological Products, (No Diag	Warburg Pincus Private Equity X, L.P.	NY	DT		P	2,896	11.44	1	253	4	6,268	D	16	-27	24	53	61	60	7	1	-3	-11	-14	-20	-21	33
12/16/11 16:43	12/14/11	CBPO	Health	BioPrd	Biological Products, (No Diag	Warburg Pincus Private Equity X, L.P.	NY	DT		P.m	2,880	11.36	1	253	4	6,015	D	16	-34	15	54	56	52	9	-2	-1	-8	-24	-20	-25	33
12/14/11 16:11	12/12/11	CBPO	Health	BioPrd	Biological Products, (No Diag	Warburg Pincus Private Equity X, L.P.	NY	DT		P.m	907	11.43	0	79	1	5,761	D	14	-26	14	55	55	66	21	3	-4	-6	-18	-22	-21	32
12/12/11 17:53	12/9/11	CBPO	Health	BioPrd	Biological Products, (No Diag	Warburg Pincus Private Equity X, L.P.	NY	DT		P	572	11.53	0	50	1	5,682	D	26	-25	10	29	34	61	35	8	0	1	-9	-22	-14	34
12/9/11 16:11	12/7/11	CBPO	Health	BioPrd	Biological Products, (No Diag	Warburg Pincus Private Equity X, L.P.	NY	DT		P.m	623	10.79	0	58	1	5,632	D	22	-20	2	32	36	59	54	14	3	1	-6	-20	-10	34
12/7/11 16:12	12/5/11	CBPO	Health	BioPrd	Biological Products, (No Diag	Warburg Pincus Private Equity X, L.P.	NY	DT		P	1,016	10.07	0	101	2	5,574	D	13	-19	-5	43	17	47	40	16	2	6	-5	-19	-13	31
12/5/11 16:13	12/1/11	CBPO	Health	BioPrd	Biological Products, (No Diag	Warburg Pincus Private Equity X, L.P.	NY	DT		P.m	69	8.77	0	8	0	5,474	D	3	-18	-6	26	21	33	37	31	6	15	1	-9	-12	42
12/1/11 16:17	11/29/11	CBPO	Health	BioPrd	Biological Products, (No Diag	Warburg Pincus Private Equity X, L.P.	NY	DT		P.m	327	7.49	0	44	1	5,466	D	-13	-27	-27	11	-7	17	19	11	6	23	17	6	-4	69
5/31/11 17:09	5/26/11	CBPO	Health	BioPrd	Biological Products, (No Diag	Warburg Pincus Private Equity X, L.P.	NY	DT		P.m	3,355	16.20	1	207	4	5,422	D	246	25	47	-4	8	14	11	5	-17	-22	-22	-36	-39	-35
5/26/11 18:06	5/24/11	CBPO	Health	BioPrd	Biological Products, (No Diag	Warburg Pincus Private Equity X, L.P.	NY	DT		P.m	4,441	15.18	1	292	6	5,215	D	246	20	56	-3	6	18	18	8	-2	-31	-40	-51	-58	-53
5/24/11 18:48	5/20/11	CBPO	Health	BioPrd	Biological Products, (No Diag	Warburg Pincus Private Equity X, L.P.	NY	DT		P.m	519	14.87	1	35	1	4,922	D	257	16	46	-11	-5	6	7	3	6	-10	-35	-49	-55	-48
5/20/11 18:15	5/18/11	CBPO	Health	BioPrd	Biological Products, (No Diag	Warburg Pincus Private Equity X, L.P.	NY	T		P.m	972	14.40	1	68	1	4,888	D	263	20	34	-12	-5	7	1	8	0	10	-37	-46	-53	-46
12/17/10 13:23	12/15/10	CBPO	Health	BioPrd	Biological Products, (No Diag	Warburg Pincus Private Equity X, L.P.	NY	T		P.m	2,467	16.45	2	150	3	4,820	D	762	76	60	79	69	58	33	10	-7	-8	-7	-9	-43	-34

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact